Chemoinformaics analysis of 2-Methyltetrahydrofuran-3-one
Molecular Weight | 100.117 | nRot | 0 |
Heavy Atom Molecular Weight | 92.053 | nRig | 6 |
Exact Molecular Weight | 100.052 | nRing | 1 |
Solubility: LogS | 0.579 | nHRing | 1 |
Solubility: LogP | -0.085 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 15.2883 |
nHD | 0 | BPOL | 10.6297 |
QED | 0.439 |
Synth | 3.567 |
Natural Product Likeliness | 1.025 |
NR-PPAR-gamma | 0.053 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.004 |
HIA | 0.004 |
CACO-2 | -4.25 |
MDCK | 0.0000296 |
BBB | 0.745 |
PPB | 0.169786 |
VDSS | 1.09 |
FU | 0.839613 |
CYP1A2-inh | 0.051 |
CYP1A2-sub | 0.647 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.698 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.265 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.481 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.231 |
CL | 6.265 |
T12 | 0.896 |
hERG | 0.015 |
Ames | 0.677 |
ROA | 0.318 |
SkinSen | 0.36 |
Carcinogencity | 0.308 |
EI | 0.958 |
Respiratory | 0.042 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.940861 |